Lovisa Sunesson

Director of Business Development at Vesper Bio

Speaker

Lovisa joined Vesper Bio in 2024 as Director of Business Development. She obtained her MSc degree in biomedicine and PhD degree in molecular medicine from Lund University, Sweden. Her research focused on the childhood cancer neuroblastoma and the neurodegenerative disease called ALS.

Prior to joining Vesper Bio, Lovisa was an associate director in business development for a global clinical mid-sized CRO. She brings over 15 years of experience in various business development positions across Medicon Valley, one of Europe's leading Life Science clusters.

Lovisa serves on the board for Commentor AB. She is a member of the Nordic Pharma Licensing Group.